<DOC>
	<DOCNO>NCT00376675</DOCNO>
	<brief_summary>RATIONALE : Methylphenidate may help relieve fatigue cause cancer . It yet know whether methylphenidate effective placebo relieve fatigue improve quality life patient cancer . PURPOSE : This randomized phase III trial study methylphenidate see well work treat patient fatigue caused cancer .</brief_summary>
	<brief_title>Methylphenidate Treating Patients With Fatigue Caused Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Test efficacy long-acting methylphenidate patient cancer-related fatigue measure use item Brief Fatigue Inventory . Secondary - Evaluate tolerability adverse event associate drug patient . - Study effect drug quality life ( QOL ) -related variable ( vitality , sleep quality , overall QOL , QOL domains , fatigue measure , perceive treatment efficacy ) patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord disease stage ( 0 , I , II v III IV ) , level fatigue baseline ( 4-7 v 8-10 ) , concurrent biological therapy ( yes v ) , concurrent chemotherapy ( yes v ) , concurrent radiotherapy ( yes v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral methylphenidate daily day 1-28 . - Arm II : Patients receive oral placebo daily day 1-28 . Patients arm complete questionnaire assess symptom fatigue , overall mood , quality life , sleep quality , adverse effect treatment baseline weekly 4 week . Patients also complete Symptom Experience Diary . McNeil Consumer &amp; Specialty Pharmaceuticals provide medication support NCCTG N05C7 . PROJECTED ACCRUAL : A total 140 patient accrue study .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . ≥ 18 year age 2 . Men woman history cancerrelated fatigue define score ≥ 4 fatigue numerical analogue scale ( 0 10 ) 3 . Fatigue ≥ 1 month prior registration 4 . ECOG Performance Score ( PS ) 0 , 1 , 2 5 . Life expectancy ≥ 6 month 6 . Histologic cytologic proven cancer brain cancer CNS lymphoma 7 . Laboratory value obtain ≤ 30 day prior registration : Hgb ≥ 10 g/dL 8 . Willing able provide inform consent 9 . Negative pregnancy test ( urine serum ) do ≤ 7 day prior registration , woman childbearing potential 10 . Ability complete questionnaire ( ) assistance 11 . Biological therapy ( i.e . immunotherapy , biotherapy ) , chemotherapy radiation therapy allow 12 . Use stable dose antidepressant ( except tricyclic antidepressant ) allow 13 . Erythropoietic agent treat anemia , steroid part cancer treatment symptom management ( except fatigue ) allow 1 . Hypersensitivity methylphenidate 2 . Any prior use methylphenidate 3 . Concomitant ( ≤ 2 week ) use prescription stimulant ( pemoline , modafinil , amphetamine ) ; medication , herbal product dietary supplement fatigue 4 . Uncontrolled hypertension [ define systolic blood pressure ( BP ) ≥ 160 mmHg and/or diastolic BP ≥ 100 mmHg 2 separate visit ≤ 2 month prior randomization ] ; rest heart rate &gt; 100 5 . Moderate severe pain defined average daily score ≥ 4 pain analog scale ( 0 10 ) 6 . Known brain metastasis primary CNS malignancy 7 . Clinically significant acute chronic progressive unstable neurologic ( dementia , delirium , seizure disorder ) , hepatic , renal , cardiovascular , thyroid , respiratory disease would limit participation study per MD discretion judgment 8 . Psychiatric disorder manic depression , anxiety disorder , bipolar disorder , obsessive compulsive disorder , schizophrenia 9 . Major surgery &lt; 4 week prior registration . ( Note : Insertion central venous catheter consider major surgery . ) 10 . Using drug contraindicate take concurrently methylphenidate : coumarin anticoagulant , anticonvulsant , tricyclic antidepressant , antipsychotic , monoamine oxidase inhibitor , clonidine , theophylline , pseudoephedrine Note : use Compazine prescribe antiemetic permit use participate study . 11 . Additional medical condition use methylphenidate contraindicate : glaucoma , motor tic , family history diagnosis Tourette 's syndrome , history drug alcohol abuse intestinal obstruction . 12 . Pregnant woman nurse woman . Women childbearing potential unwilling employ adequate contraception . This study involve investigational agent whose genotoxic , mutagenic , teratogenic effect develop fetus newborn unknown . 13 . Untreated hypothyroidism ( TSH ≥ 5 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>fatigue</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>